La Habana, Cuba

Ernesto Moreno Frias


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 270(Granted Patents)


Location History:

  • Havana, CU (1999)
  • La Habana, CU (2016)

Company Filing History:


Years Active: 1999-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ernesto Moreno Frias: Pioneering Advances in Monoclonal Antibodies

Introduction: Ernesto Moreno Frias, an accomplished inventor based in La Habana, Cuba, has made significant contributions to the field of biomedicine through his innovative work on monoclonal antibodies. With a portfolio of two patents, Frias has focused on developing antibodies with dual specificity that hold promise for cancer therapy and diagnosis.

Latest Patents: The latest patents attributed to Ernesto Moreno Frias include groundbreaking inventions in the realm of recombinant antibodies. His first patent describes new monoclonal antibodies and fragments that exhibit dual specificity and high affinity for N-acetyl GM3 and N-glycolyl GM3, without recognizing other gangliosides. This invention is crucial for developing therapeutic applications targeting tumors that significantly express these antigens. Furthermore, Frias's other patent introduces humanized and chimeric monoclonal antibodies that recognize the Epidermal Growth Factor Receptor (EGF-R), incorporating an artificial sequence in the heavy chain variable region of human immunoglobulins.

Career Highlights: Throughout his career, Ernesto Moreno Frias has worked with esteemed organizations such as the Centro de Inmunología Molecular and Centro de Immunología Molecular. His dedication to advancing medical science through innovative antibody research has established him as a prominent figure in his field.

Collaborations: Frias has collaborated with talented professionals in his career, including Cristina Maria Mateo de Acosta del Rio and Rolando Perez Rodriguez. Together, they have contributed to the scientific community through their joint efforts in monoclonal antibody research.

Conclusion: Ernesto Moreno Frias exemplifies the spirit of innovation and dedication to improving healthcare through his pioneering work on monoclonal antibodies. His patents reflect a profound understanding of the complexities involved in targeting specific antigens, offering potential breakthroughs in cancer therapy and diagnosis. As the biomedicine field continues to evolve, Frias's contributions will undoubtedly leave a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…